Search research articles
Contact Us
Filters
Showing results (41-50 of 273) with videos related to
Page
of 28
Sort By:
Lancet (London, England)
|
June 4, 2013
SYNTAX score II
Parvin Tajik, Katrien Oude Rengerink, Ben Willem Mol, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 22, 2013
Trial designs for personalizing cancer care: a systematic review and classification
Parvin Tajik, Aleiko H Zwinderman, Ben W Mol, et al.
Diagnostic and Prognostic Research
|
January 1, 2020
Targeted test evaluation: a framework for designing diagnostic accuracy studies with clear study hypotheses
Daniël A Korevaar, Gowri Gopalakrishna, Jérémie F Cohen, et al.
The Lancet. Gastroenterology & Hepatology
|
August 8, 2019
The harms of early cessation of trials on systematic reviews - Authors' reply
Marcel G Dijkgraaf, Jony van Hilst, Patrick M Bossuyt, et al.
The Lancet. Respiratory Medicine
|
February 2, 2017
Is there added value in adding EUS to EBUS? - Authors' reply
Daniël A Korevaar, Laurence M Crombag, Patrick M Bossuyt, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)
|
November 22, 2012
A feces collection paper does not enhance participation in a fecal immunochemical test-based colorectal cancer screening program: randomized clinical trial
Maaike J Denters, Marije Deutekom, Patrick M Bossuyt, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)
|
March 4, 2015
Most participate in faecal immunochemical test-based colorectal cancer screening out of curiosity about their chances of developing cancer
Maaike J Denters, Patrick M Bossuyt, Marije Deutekom, et al.
Plos One
|
July 8, 2015
Aspirin for Primary Prevention of Cardiovascular Disease and Cancer. A Benefit and Harm Analysis
Inge Stegeman, Patrick M Bossuyt, Tsung Yu, et al.
Annals of Translational Medicine
|
March 23, 2016
STARD 2015: updated reporting guidelines for all diagnostic accuracy studies
Patrick M Bossuyt, Jérémie F Cohen, Constantine A Gatsonis, et al.
The American Journal of Gastroenterology
|
August 31, 2018
Participant-Related Risk Factors for False-Positive and False-Negative Fecal Immunochemical Tests in Colorectal Cancer Screening: Systematic Review and Meta-Analysis
Clasine M de Klerk, Lisanne M Vendrig, Patrick M Bossuyt, et al.
Page
of 28
Search research articles
Search
Showing results (41-50 of 273) with videos related to
Sort By:
Page
of 28
Lancet (London, England)
|
June 4, 2013
SYNTAX score II
Parvin Tajik, Katrien Oude Rengerink, Ben Willem Mol, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 22, 2013
Trial designs for personalizing cancer care: a systematic review and classification
Parvin Tajik, Aleiko H Zwinderman, Ben W Mol, et al.
Diagnostic and Prognostic Research
|
January 1, 2020
Targeted test evaluation: a framework for designing diagnostic accuracy studies with clear study hypotheses
Daniël A Korevaar, Gowri Gopalakrishna, Jérémie F Cohen, et al.
The Lancet. Gastroenterology & Hepatology
|
August 8, 2019
The harms of early cessation of trials on systematic reviews - Authors' reply
Marcel G Dijkgraaf, Jony van Hilst, Patrick M Bossuyt, et al.
The Lancet. Respiratory Medicine
|
February 2, 2017
Is there added value in adding EUS to EBUS? - Authors' reply
Daniël A Korevaar, Laurence M Crombag, Patrick M Bossuyt, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)
|
November 22, 2012
A feces collection paper does not enhance participation in a fecal immunochemical test-based colorectal cancer screening program: randomized clinical trial
Maaike J Denters, Marije Deutekom, Patrick M Bossuyt, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)
|
March 4, 2015
Most participate in faecal immunochemical test-based colorectal cancer screening out of curiosity about their chances of developing cancer
Maaike J Denters, Patrick M Bossuyt, Marije Deutekom, et al.
Plos One
|
July 8, 2015
Aspirin for Primary Prevention of Cardiovascular Disease and Cancer. A Benefit and Harm Analysis
Inge Stegeman, Patrick M Bossuyt, Tsung Yu, et al.
Annals of Translational Medicine
|
March 23, 2016
STARD 2015: updated reporting guidelines for all diagnostic accuracy studies
Patrick M Bossuyt, Jérémie F Cohen, Constantine A Gatsonis, et al.
The American Journal of Gastroenterology
|
August 31, 2018
Participant-Related Risk Factors for False-Positive and False-Negative Fecal Immunochemical Tests in Colorectal Cancer Screening: Systematic Review and Meta-Analysis
Clasine M de Klerk, Lisanne M Vendrig, Patrick M Bossuyt, et al.
Page
of 28